Indication Based Prescribing
Medicare part D insurers are changing the way they look at drugs.
WHAT is it
Prescribing is Changing
In 2020, Medicare part D insurers will have the option of accepting or denying prescription coverage based on the reason for the prescription. Documenting the reason for each prescription will be required if providers want to avoid insurance coverage issues and administrative headaches.
This practice (called indication-based formulary) is currently not part of EMR systems (except for opioids) as prescriptions are currently not indication based but GoToPills is.
GoToPills Changes Everything
GoToPills is ahead of this curve. Each medication in the database is associated with a convenient drop-down menu that makes indication-based prescribing hassle-free.
Better medication adherence when patients understand why prescribed
Medication mistakes are reduced with look-alike drug names
Detection of drug selection and dosing errors
Avoid errors involving the wrong patient
Duplicate therapy and continuation of medications that are no longer needed
The ability to measure a drug’s long-term effectiveness is enhanced
Access where you need it
GoToPills availability in Epic (and coming soon to Cerner) provides a tremendous opportunity to expand the reach of GoToPills both nationally and internationally and furthers our mission of delivering easily accessible, comprehensive, and concise information about off-label medications.
Web Portal
Access our tools using your web browser.
Mobile App
Use the tools while on the go from your mobile device.
EPIC EHR
Find us in the EPIC system as part of the encounter workflow.
Cerner EHR
Use the system from your drop-down in the prescribing view.
(COMING SOON)
play it safe
Increase Patient Safety
GoToPills off-label prescribing tools are designed to increase patient safety and decrease liability risks associated with off-label medications. With the indication-based prescribing changes, GoToPills supplies the vital information that is needed to avoid costly administrative headaches when medication coverage is denied.
